Physician profile
Marc Vimolratana
NPI 1467870683
$4,857.34
in general payments reported to CMS, 2019-2025
9 companies · $525 in 2025
The $525 reported for 2025 was more than what 80% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $621 · 2021: $271 · 2022: $613 · 2023: $68.12 · 2024: $2,761 · 2025: $525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,792 · Travel and Lodging: $1,561.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,791.80 |
| Travel and Lodging | $1,561.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $3,454.68 | 2021-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Astrazeneca Pharmaceuticals LP | $466.81 | 2022-2025 | Imfinzi, Calquence |
| Medtronic Vascular, INC. | $319.02 | 2020 | |
| Edwards Lifesciences Corporation | $170.52 | 2020-2021 | |
| Medtronic, INC. | $150.92 | 2025 | |
| Davol INC. | $144.98 | 2020 | |
| Philips North America LLC | $68.12 | 2023 | |
| Merck Sharp & Dohme LLC | $56.73 | 2025 | Keytruda |
| Baxter Healthcare | $25.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Vimolratana listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.